- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01673568
Abdominal Binder to Reduce Pain and Seroma Formation (ABD- BINDER)
Postoperative Abdominal Binder in Reducing Seroma Formation and Pain After Ventral (Umbi/Epi) Hernia Repair.
Postoperative seroma formation is one of the most common complications after ventral hernia repair. Although some seromas may not have clinical impact, postoperative seroma formation often causes pain and discomfort and may even compromise wound healing. The use of postoperative abdominal binder is often recommended after ventral hernia repair to prevent seroma and diminish pain, but still with no scientific evidence. The primary aim of the present study is to investigate the effect of postoperative abdominal binders after laparoscopic ventral hernia repair on postoperative pain, discomfort and quality of life. Secondary, we register seroma formation.
Method and material Randomized, controlled, multi-center, investigator-blinded study. A minimum of 56 patients (2X28 umbi/epi) are included, inclusion number is based on power calculations. Patients are randomized either to abdominal binder or no abdominal binder. The abdominal binder is worn from immediately after the operation and continuously for 7 days, night and day. Outcomes are based on patient self-reported registrations using Visual Analog Scales (VAS) and Carolina Comfort Scale (CCS), which is a validated, hernia-specific tool to estimate quality of life, pain and discomfort. Patients are followed-up for 30 days. For secondary outcome we use ultrasound to measure the volume of seroma formation. We use Mann-Witney, non-parametric statistics calculating the seroma formation and Friedmanns test for pain, discomfort and quality of life for the effect of time on inter- and intragroup differences during the study period. P < 0.05 is considered significant.
Study Overview
Detailed Description
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
CPH
-
Hvidovre, CPH, Denmark, 2650
- Hvidovre Hospital
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Elective, primary and recurrent laparoscopic umbilical and epigastric hernia repair with mesh reinforcement
- Fascia defects 2-8 cm measured preoperatively by the surgeon at the out-patient clinic for umbi/epi
- Elective, primary and recurrent laparoscopic trocar-site hernia
- Patients between 18-80 years
Exclusion Criteria:
- Open ventral hernia repair
- Expected low compliance (language problems, dementia and abuse etc.)
- Fascia defects >8 cm at the preoperative clinical examination.
- Acute operation
- Chronic pain syndrome
- Decompensated liver cirrhosis (Child-Pugh B-C)
- Patients with a stoma
- If a secondary operation is performed during the hernia repair procedure
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Active Comparator: abdominal binder
The abdominal binder is worn from immediately after the operation and continuously for 7 days, night and day.
The belts are standard elastic belts (ostomy belts) from "ETO garments©" with standard height of 22 cm.
and five different sizes in width (S, M, L, XL, XXL- depending on waist measure).
A fitting will be done before the operation by waist measurement according to the recommendation from the company.
|
patients wearing abdominal binder for 7 days postoperatively
Other Names:
|
No Intervention: no abdominal binder
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Visual Analog Scale of Pain Activity
Time Frame: 24 hours after hernia repair
|
Outcome is based on patient self-reported registrations using Visual Analog Scales (VAS) where 0 is no pain in activity and 100 is worst imaginable pain in activity.
|
24 hours after hernia repair
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Seroma Formation
Time Frame: postoperative day 7
|
Seroma formation measured on day 7 postoperatively with trans abdominal ultrasound scan (US).
The method used in this study to estimate the volume of seroma is to measure the longitudinal section and cross section of the effusion and thereby calculating the volume.
|
postoperative day 7
|
Collaborators and Investigators
Sponsor
Collaborators
Investigators
- Study Director: Thue Bisgaard, MD, University Hospital Hvidovre
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- AB-BINDER
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Ventral Hernias
-
Cook Group IncorporatedWithdrawnIncisional Hernias | Ventral Hernias
-
Cook Group IncorporatedCompleted
-
Hvidovre University HospitalUniversity of CopenhagenCompleted
-
University Hospital, GhentJohnson & JohnsonCompletedUmbilical Hernias | Ventral HerniasBelgium
-
Assiut UniversityCompletedVentral Hernias in Cirrhotic Patients
-
Varazdin General HospitalCompletedIncisional Ventral Hernia | Recurrent Ventral HerniaCroatia
-
Zealand University HospitalBispebjerg Hospital; University Hospital, Gentofte, CopenhagenCompletedInguinal Hernia | Incisional Hernia | Umbilical HerniasDenmark
-
Sofregen Medical, Inc.TerminatedVentral Hernia RepairUnited States
-
Anne Arundel Health System Research InstituteMedtronic - MITGCompletedGrade I Ventral Hernia | Grade II Ventral HerniaUnited States
-
Zaza DemetrashviliRecruitingLarge Midline Ventral HerniaGeorgia
Clinical Trials on ETO garments
-
Hvidovre University HospitalWithdrawnIncisional HerniaDenmark
-
Johns Hopkins UniversityAD RescueWearWithdrawnAtopic DermatitisUnited States
-
Novatex MedicalEVAMEDActive, not recruitingEhlers-Danlos SyndromeFrance
-
The University of Texas Medical Branch, GalvestonU.S. Department of EducationWithdrawn
-
Centre Mutualiste de Rééducation et de Réadaptation...Fondation Rothschild Paris; Clinique Mutualiste Lorient; Groupement des Hopitaux...RecruitingComplex Regional Pain SyndromesFrance
-
CerecareCompletedEds, Unspecified TypeFrance
-
St Mary's University CollegeCompleted
-
IRCCS Eugenio MedeaRecruiting
-
M.D. Lederman Consulting LtdCompletedUlcer | Leg Ulcer | Skin Ulcer | Venous UlcerIsrael
-
University of HaifaCompletedHealthy Runners. Compression Stocking and PerformanceIsrael